Literature DB >> 15664944

Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.

Ravichandran Palaniappan1, Shailesh Singh, Udai P Singh, Senthil Kumar K Sakthivel, Edwin W Ades, David E Briles, Susan K Hollingshead, James C Paton, Jacquelyn S Sampson, James W Lillard.   

Abstract

Larger numbers of pneumococci were detected in the nasal tract compared to the lung, cervical lymph nodes, and spleen 1, 2, 4, 7, 14, and 21 days after nasal challenge with Streptococcus pneumoniae strain EF3030. In this mouse model of pneumococcal carriage, peripheral S. pneumoniae pneumococcal surface adhesin A (PsaA)-specific humoral responses (immunoglobulin G2a [IgG2a] >> IgG1 = IgG2b > IgG3) were significantly higher than pneumococcal surface protein A (PspA)-specific, genetic toxoid derivative of pneumolysin (PdB)-specific, or pneumococcal surface protein C (PspC)-specific serum antibody levels. However, PspA-specific mucosal IgA antibody levels were significantly higher than those against PsaA, PdB, and PspC. In general, both PsaA- and PspA-specific lung-, cervical lymph node-, nasal tract-, and spleen-derived CD4(+) T-cell cytokine (interleukin-4, interleukin-6, granulocyte-macrophage colony-stimulating factor, gamma interferon, and tumor necrosis factor alpha) and proliferative responses were higher than those for either PspC or PdB. Taken together, these findings suggest that PsaA- and PspA-specific mucosal responses as well as systemic humoral and T helper cell cytokine responses are predominantly yet differentially induced during pneumococcal carriage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664944      PMCID: PMC547096          DOI: 10.1128/IAI.73.2.1006-1013.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.

Authors:  D E Briles; E Ades; J C Paton; J S Sampson; G M Carlone; R C Huebner; A Virolainen; E Swiatlo; S K Hollingshead
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Pneumococcal surface adhesin A antibody concentration in serum and nasopharyngeal carriage of Streptococcus pneumoniae in young African infants.

Authors:  S K Obaro; R A Adegbola; J A Tharpe; E W Ades; K P McAdam; G Carlone; J S Sampson
Journal:  Vaccine       Date:  2000-10-15       Impact factor: 3.641

3.  Host cellular immune response to pneumococcal lung infection in mice.

Authors:  A Kadioglu; N A Gingles; K Grattan; A Kerr; T J Mitchell; P W Andrew
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  PspC, a pneumococcal surface protein, binds human factor H.

Authors:  S Dave; A Brooks-Walter; M K Pangburn; L S McDaniel
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.

Authors:  S Rapola; V Jäntti; R Haikala; R Syrjänen; G M Carlone; J S Sampson; D E Briles; J C Paton; A K Takala; T M Kilpi; H Käyhty
Journal:  J Infect Dis       Date:  2000-09-05       Impact factor: 5.226

6.  Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia.

Authors:  E Wang; M Simard; N Ouellet; Y Bergeron; D Beauchamp; M G Bergeron
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

7.  Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.

Authors:  D E Briles; S K Hollingshead; J King; A Swift; P A Braun; M K Park; L M Ferguson; M H Nahm; G S Nabors
Journal:  J Infect Dis       Date:  2000-11-08       Impact factor: 5.226

Review 8.  Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: report and review of recent outbreaks.

Authors:  S Gleich; Y Morad; R Echague; J R Miller; J Kornblum; J S Sampson; J C Butler
Journal:  Infect Control Hosp Epidemiol       Date:  2000-11       Impact factor: 3.254

9.  Selection of an immunogenic and protective epitope of the PsaA protein of Streptococcus pneumoniae using a phage display library.

Authors:  N Srivastava; J L Zeiler; S L Smithson; G M Carlone; E W Ades; J S Sampson; S E Johnson; T Kieber-Emmons; M A Westerink
Journal:  Hybridoma       Date:  2000-02

10.  The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia.

Authors:  A Brooks-Walter; D E Briles; S K Hollingshead
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

View more
  19 in total

1.  Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo.

Authors:  Laura R Marks; G Iyer Parameswaran; Anders P Hakansson
Journal:  Infect Immun       Date:  2012-05-29       Impact factor: 3.441

Review 2.  Lipoproteins of bacterial pathogens.

Authors:  A Kovacs-Simon; R W Titball; S L Michell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil.

Authors:  Fabiana Cristina Pimenta; Fátima Ribeiro-Dias; Maria Cristina C Brandileone; Eliane N Miyaji; Luciana C C Leite; Ana Lúcia S Sgambatti de Andrade
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

4.  Intranasal immunization with autolysin (LytA) in mice model induced protection against five prevalent Streptococcus pneumoniae serotypes in China.

Authors:  Zhu Qing Yuan; Zhi Yue Lv; Hui Quan Gan; Mo Xian; Kou Xing Zhang; Jing Ying Mai; Xin Bing Yu; Zhong Dao Wu
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

5.  Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo.

Authors:  Antonia C Perez; Bing Pang; Lauren B King; Li Tan; Kyle A Murrah; Jennifer L Reimche; John T Wren; Stephen H Richardson; Uma Ghandi; W Edward Swords
Journal:  Pathog Dis       Date:  2014-02-03       Impact factor: 3.166

6.  Asthma and antibodies to pneumococcal virulence proteins.

Authors:  H Zhao; J A Jung; D E Briles; H Kita; C Tsigrelis; Y J Juhn
Journal:  Infection       Date:  2013-06-08       Impact factor: 3.553

7.  Functional characterization of the IlpA protein of Vibrio vulnificus as an adhesin and its role in bacterial pathogenesis.

Authors:  Kyung-Jo Lee; Na Yeon Lee; Yang-Soo Han; Juri Kim; Kyu-Ho Lee; Soon-Jung Park
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

8.  Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.

Authors:  Rajesh Singh; Shailesh Singh; Praveen K Sharma; Udai P Singh; David E Briles; Susan K Hollingshead; James W Lillard
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

9.  Addiction of Hypertransformable Pneumococcal Isolates to Natural Transformation for In Vivo Fitness and Virulence.

Authors:  Guiling Li; Zhuowen Liang; Xiatai Wang; Yonghong Yang; Zhujun Shao; Machao Li; Yueyun Ma; Fen Qu; Donald A Morrison; Jing-Ren Zhang
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

10.  Pneumococcal PspA and PspC proteins: potential vaccine candidates for experimental otitis media.

Authors:  Patricia A Schachern; Vladimir Tsuprun; Patricia Ferrieri; David E Briles; Sarah Goetz; Sebahattin Cureoglu; Michael M Paparella; Steven Juhn
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-06-24       Impact factor: 1.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.